Status:
RECRUITING
Hantavirus Registry - HantaReg
Lead Sponsor:
University of Cologne
Conditions:
Hantavirus Infections
Hemorrhagic Fever With Renal Syndrome
Eligibility:
All Genders
Brief Summary
Hantavirus disease are zoonotic infections and remain a clinical challenge with globally increasing incidence and multiple serious outbreak situations in Europe within the last years. Hantavirus disea...
Detailed Description
Hantavirus disease are zoonotic infections and remain a clinical challenge with globally increasing incidence and multiple serious outbreak situations in Europe within the last years. Hantavirus disea...
Eligibility Criteria
Inclusion
- Serological or molecular evidence of hantavirus infection and clinical evidence of nephropathia epidemica or hemorrhagic fever with renal syndrome (HFRS)
- Serological or molecular evidence of hantavirus infection and clinical evidence of hantavirus cardiopulmonary syndrome (HCPS)
Exclusion
- \- Serological or molecular evidence of hantavirus infection without clinical signs of nephropathia epidemica, HFRS or HCPS
Key Trial Info
Start Date :
March 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04323904
Start Date
March 4 2020
End Date
December 1 2030
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Cologne
Cologne, North-Rhine Westfalia, Germany, 50937